APA (7th ed.) Citation

Seyfried, N., Yurttas, C., Burkard, M., Oswald, B., Tolios, A., Herster, F., . . . Löffler, M. W. (2022). Prolonged Exposure to Oxaliplatin during HIPEC Improves Effectiveness in a Preclinical Micrometastasis Model. Cancers, 14(5), 1158. https://doi.org/10.3390/cancers14051158

Chicago Style (17th ed.) Citation

Seyfried, Nick, et al. "Prolonged Exposure to Oxaliplatin During HIPEC Improves Effectiveness in a Preclinical Micrometastasis Model." Cancers 14, no. 5 (2022): 1158. https://doi.org/10.3390/cancers14051158.

MLA (9th ed.) Citation

Seyfried, Nick, et al. "Prolonged Exposure to Oxaliplatin During HIPEC Improves Effectiveness in a Preclinical Micrometastasis Model." Cancers, vol. 14, no. 5, 2022, p. 1158, https://doi.org/10.3390/cancers14051158.